...
机译:HCV HCV对近期感染治疗的个体中的发病率
Viral Hepatitis Clinical Research ProgramUNSW AustraliaSydney NSW Australia;
Viral Hepatitis Clinical Research ProgramUNSW AustraliaSydney NSW Australia;
Viral Hepatitis Clinical Research ProgramUNSW AustraliaSydney NSW Australia;
Auckland HospitalAuckland New Zealand;
Centre for Population HealthBurnet InstituteMelbourne Vic. Australia;
Infectious Diseases UnitRoyal Adelaide HospitalAdelaide SA Australia;
Victorian Infectious Diseases ServiceRoyal Melbourne HospitalMelbourne Vic. Australia;
Viral Hepatitis Clinical Research ProgramUNSW AustraliaSydney NSW Australia;
Viral Hepatitis Clinical Research ProgramUNSW AustraliaSydney NSW Australia;
Viral Hepatitis Clinical Research ProgramUNSW AustraliaSydney NSW Australia;
acute; hepatitis C infection; HIV; recent; reinfection; treatment;
机译:编辑到Martinello等人。在为近期感染治疗的个体中的HCV HCV再感染发生率
机译:HCV艾滋病毒阳性男性的HCV Reinfection发病率和自发性清除率与西欧有关系
机译:在圣地亚哥与男性发生性关系的艾滋病毒感染的男性成功治疗后,HCV再感染发生率升高
机译:Peginterferon Alfa-2a(Pegasys)的安全性为180 mcg每周加上利韦韦林(RBV)800mg在HIV / HCV辛纤维中每日800毫克,与HCV单键相比
机译:血腥病毒感染HBV,HCV,艾滋病毒 - 护士中职业风险和预防=血液接触性病毒感染 - 乙型肝炎,C,艾滋病 - 护士中的专业风险和预防
机译:接受近期感染的个体中HCV再感染的发生率
机译:接受近期感染的个体中HCV再感染的发生率